Tacriva 0.03% Ointment
Manufacturer
Rivan Pharma
Salt Composition
Tacrolimus (0.03% w/w)
Key Information
Short Description
Tacriva 0.03% Ointment is used to treat eczema (atopic dermatitis) by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin.
Dosage Form
Ointment
Introduction
Tacriva 0.03% Ointment is used for external use. It should be used 2-4 times a day on the affected area or use it as suggested by the doctor. It should be applied slowly and evenly to the skin until it is rubbed in. You should not use it too often and you should not cover the treated area with a bandage or plaster. You must inform your doctor if there’s no improvement even after two weeks of treatment or if the skin gets worse. Use of this medicine may cause some common side effects like erythema, headache, inflammation of hair follicle, and application site reaction like burning, irritation, itching, and redness. This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed.
Directions for Use
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and gently massage the ointment.
Safety Information
Side Effects
Erythema Headache Inflammation of hair follicle Application site reaction like burning, irritation, itching, and redness
Alcohol Warning
No interaction found/established
Breastfeeding Warning
Tacriva 0.03% Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy Warning
Tacriva 0.03% Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Interacting Medicines
Rotavirus vaccine (live attenuated, oral) Live Attenuated Varicella-Zoster Virus Measles Vaccine (Live) Rubella vaccine (Live)
How it works
Tacriva 0.03% Ointment is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.
Quick Tips
Apply thinly to affected areas of skin only Clean the affected area and dry well before applying Tacriva 0.03% Ointment Avoid contact with water after application Inform your doctor if there's no improvement even after two weeks of treatment or if the skin gets worse Don't cover the area being treated with airtight dressings such as bandages unless directed by a doctor Stop using Tacriva 0.03% Ointment and consult your doctor if your eczema becomes infected Continuous long-term use of the ointment should be avoided. Use as prescribed by your doctor
Related Medicines
Tacvido Ointment
Tacroz Ointment
Tacrovera Ointment
Tacroz Ointment
Talimus LS Ointment
Taclix 0.03% Ointment
Tacrolix Ointment
T Mus 0.03% Ointment
Tachop 0.03% Ointment
Pangraf 0.03% Ointment
Frequently asked questions
What is Tacriva 0.03% Ointment used for?
Tacriva 0.03% Ointment is a medicine designed to modulate the immune system, reducing its activity. It's specifically indicated for treating moderate to severe eczema (atopic dermatitis) in adults who experience insufficient response to or are experiencing adverse effects from using topical corticosteroids.
What are the side effects of Tacriva 0.03% Ointment?
Tacriva 0.03% Ointment, when applied topically, may cause skin irritation, burning sensation, and itching at the application site. These typically manifest as mild to moderate symptoms and often subside within a week of commencing treatment. Redness is also commonly observed alongside feelings of warmth, pain, altered sensation, and rash at the application site. Furthermore, using Tacriva 0.03% Ointment increases the risk of inflammation or infection in hair follicles, cold sores, acne, and generalized herpes simplex infections.
Is Tacriva 0.03% Ointment safe?
Compared to other immunosuppressive medications, Tacriva 0.03% Ointment has proven to be a safe and effective short-term treatment for atopic dermatitis. Its absorption from the skin into the bloodstream is minimal, resulting in reduced side effects compared to oral administration.
Does Tacriva 0.03% Ointment have abuse potential?
No, Tacriva 0.03% Ointment does not possess abuse potential and therefore is not classified as a controlled substance. Controlled substances are those that hold the potential for misuse and require specific authorization from authorities or healthcare professionals before use.
Does Tacriva 0.03% Ointment cause cancer?
Long-term use of Tacriva 0.03% Ointment has been associated with an increased risk of developing lymph node tumors, specifically lymphoma. Some studies have linked its use to skin cancers or lymphoma in certain individuals.
Is Tacriva 0.03% Ointment a steroid?
No, Tacriva 0.03% Ointment is not a steroid. It is a medicine that modulates the immune system. Its use in eczema treatment is primarily aimed at reducing immune system activity and addressing its overreaction, resulting in skin inflammation, itching, redness, and dryness.
